Literature DB >> 17699302

Dialysis at a crossroads: reverse engineering renal replacement therapy.

Jonathan Himmelfarb1.   

Abstract

Mesh：

Year:  2006        PMID： 17699302     DOI： 10.2215/CJN.10911105

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  2 in total

1.  Health Policy for Dialysis Care in Canada and the United States.

Authors:  Marcello Tonelli; Raymond Vanholder; Jonathan Himmelfarb
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-25       Impact factor: 8.237

2.  Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease.

Authors:  Sachin Jhawar; Prabhjot Singh; Daniel Torres; Francisco Ramirez-Valle; Hania Kassem; Trina Banerjee; Igor Dolgalev; Adriana Heguy; Jiri Zavadil; Jerome Lowenstein
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.